WHOOP account plan
Unlocking human performance through technology
At a glance
WHOOP is a Boston screenless health wearable sold as a membership: over 2.5 million members, a $1.1B bookings run rate and a $10.1 billion valuation.
WHOOP, founded in 2012 by Will Ahmed with John Capodilupo and Aurelian Nicolae and headquartered in Boston, sells a screenless 24/7 wearable as a subscription membership. The band measures strain, recovery and sleep continuously, and the platform now adds an FDA-cleared ECG, Blood Pressure Insights, a Healthspan feature and Advanced Labs blood testing; members range from elite athletes to executives and military operators. It has over 2.5 million members, exited 2025 with bookings growing 103% year-over-year to a $1.1B run rate, and operated cash flow positive in 2025; it ships to 56 countries. WHOOP is private and independent, backed by venture and sovereign investors: its Series G of $575 million at a $10.1 billion valuation closed on 31 March 2026, led by Collaborative Fund, and the CEO calls an IPO the next step.
Strategic priorities
- From fitness wearable to personal health platform
- WHOOP says it is building "the personal health platform that people use to improve their health and livelihood", adding clinical features: WHOOP MG with an FDA-cleared ECG and blood pressure insights (May 2025), Advanced Labs blood testing (September 2025) and a women's health panel of 11 biomarkers (March 2026).
- International expansion
- Series G proceeds fund further U.S. growth and expansion across Europe, the GCC, Latin America and Asia, plus a faster global rollout of Advanced Labs.
- AI coaching on continuous data
- The company pairs more than 24 billion hours of physiological data with purpose-built AI models; the CEO expects wearable data, blood tests and other data sets to sit "under one roof" with an AI on top within two to three years.
- Preparing for an IPO
- The CEO expects the Series G to be the last private round and says the company is "doing a lot of the no-regrets work to be a public company"; in November 2025 he put a listing "over a horizon of two years."
- Scaling the team
- More than 600 new roles opened throughout 2026 across Software, Research & Design, Hardware, Product and Marketing, mostly at the Boston headquarters, with hiring in North America, Europe, the GCC and Asia.
Latest results
WHOOP does not publish accounts. In its March 2026 funding announcement it reported over 2.5 million members, 2025 bookings growth of 103% year-over-year to exit the year at a $1.1B run rate, and positive operating cash flow in 2025. Women represented 150% year-on-year growth in new members as of early 2026. The Series G raised $575 million at a $10.1 billion valuation, nearly tripling the $3.6 billion valuation of 2021.
Investments and deals
- Series G funding
- $575 million at a $10.1 billion valuation, closed 31 March 2026, led by Collaborative Fund with QIA, Mubadala, Abbott (strategic investor), Mayo Clinic, IVP and others, plus athletes including Cristiano Ronaldo and LeBron James.
- Advanced Labs blood testing
- A panel of 65 biomarkers run by Quest Diagnostics across the United States, clinician-reviewed and synced to the app, priced from $199 for a single test to $599 for four tests a year; opened in September 2025 to a 350,000-person waitlist.
- Medical-grade hardware
- WHOOP 5.0 and WHOOP MG launched in May 2025, the MG being its first medical-grade device with an FDA-cleared electrocardiogram.
- Hiring for 2026
- Over 600 new roles worldwide in 2026 to support research and development and international expansion.
Challenges and risks
- Large, well-funded competitors
- WHOOP competes with Garmin and Apple; at $10.1 billion it is valued at roughly one quarter of Garmin's approximately $40 billion market capitalisation, and the CEO's strategy has been to avoid becoming a smartwatch.
- Proving the preventive-medicine bet
- Public investors will have to credit the bet that continuous biometric data plus periodic blood testing moves wearables from self-quantification into preventive medicine.
- Measurement accuracy
- Wrist sensing is harder across skin tones, body types and non-periodic sports; for roughly one in 20 to one in 50 users WHOOP recommends wearing the sensor on the bicep.
- Highly selective hiring at scale
- Filling over 600 roles while keeping approximately one hire for every 750 applicants, an acceptance rate of .13%.
What leadership says
“Our next step is an IPO”
“We are building the personal health platform that people use to improve their health and livelihood.”
“We are doing both.”
“All of that information is going to be under one roof.”
Where a supplier can help
- Clinical and diagnostics partnerships
- The move into a personal health platform (ECG, blood pressure, Advanced Labs) creates needs for lab, clinical-review and medical data partners in each new country.
- Market entry in Europe, the GCC, Latin America and Asia
- International expansion funded by the Series G calls for localisation, logistics, payments and retail or distribution partners in the new regions.
- AI and data infrastructure
- Running AI coaching over more than 24 billion hours of physiological data points to suppliers of data platforms, model tooling and privacy and security services.
- IPO readiness
- The no-regrets work to become a public company opens room for finance systems, reporting, governance, audit and investor-relations providers.
- Recruiting and onboarding at scale
- The plan to hire over 600 people in 2026, mostly in Boston, fits recruiting, assessment, HR and onboarding tools.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like WHOOP?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- WHOOP raises $575m at $10.1bn valuation, signals IPO ahead (The Next Web)
- WHOOP raised $575 million in a Series G round at a $10.1 billion valuation, closed on 31 March 2026, nearly tripling its last publicly reported valuation of $3.6 billion from 2021.
- Founder and CEO Will Ahmed told Yahoo Finance: "It's our expectation this is the last private round of financing that we'll do" and "Our next step is an IPO"; the company is "doing a lot of the no-regrets work to be a public company".
- Scale: more than 2.5 million members; exited 2025 with a bookings run rate of $1.1 billion, up 103% year on year; operating cash flow positive during 2025.
- Women represented 150% year-on-year growth in new members as of early 2026, and female members engage with the AI features approximately 30% more than male members.
- Product push into health: WHOOP 5.0 and WHOOP MG (first medical-grade device, FDA-cleared ECG, blood pressure insights, Healthspan / "WHOOP Age") launched in May 2025; Advanced Labs blood testing (65 biomarkers, Quest Diagnostics, $199 to $599) opened in September 2025 to a 350,000-person waitlist; a women's health panel of 11 biomarkers followed in March 2026.
- Proceeds fund U.S. growth and international expansion into Europe, the Gulf Cooperation Council, Latin America and Asia, plus a faster global rollout of Advanced Labs; a hiring surge of more than 600 roles was announced in March 2026.
- Investors include Collaborative Fund (lead), Mubadala, the Qatar Investment Authority, Abbott and Mayo Clinic; the article sets WHOOP's valuation at roughly one quarter of Garmin's (about $40 billion market capitalisation).
- WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform (press release)
- WHOOP, "the human performance company", raised $575 million in Series G funding at a $10.1 billion valuation (31 March 2026, Abu Dhabi / Boston).
- Led by Collaborative Fund, with 2PointZero Group, Qatar Investment Authority (QIA), Mubadala, Abbott, Mayo Clinic, Macquarie Capital, IVP and others, plus athletes including Cristiano Ronaldo, LeBron James and Rory McIlroy.
- Company figures: over 2.5 million members; 2025 bookings grew 103% year-over-year, exiting the year at a $1.1B run rate; operated cash flow positive in 2025.
- Hiring for over 600 new roles worldwide in 2026 for research and development and international expansion.
- Proceeds fund U.S. growth and expansion across Europe, the GCC, Latin America and Asia.
- Abbott joins as a strategic investor (diagnostics, medical devices, nutrition, generic medicines).
- Platform claims: more than 24 billion hours of physiological data and purpose-built AI models; members open the app over eight times per day on average, almost three times higher than other screenless wearables.
- Will Ahmed: "We are building the personal health platform that people use to improve their health and livelihood."
- WHOOP Announces 2026 Hiring Surge, Adding More Than 600 Roles as It Scales Wearable Health Platform Globally (press release)
- WHOOP plans to add more than 600 new roles across Software, Research & Design, Hardware, Product and Marketing, opened throughout 2026.
- Most roles will be at the Boston headquarters in Kenmore Square, with more hiring across North America, Europe, the GCC and Asia.
- Will Ahmed: "Right now, companies are debating whether to hire more people or just invest in AI," and "We are doing both." He says WHOOP "intends to own the category" of health monitoring.
- Selectivity: approximately one hire for every 750 applicants, an acceptance rate of .13%.
- Product as described: a 24/7 wearable with a 14-day battery life; FDA-cleared ECG, Healthspan, Blood Pressure Insights and Advanced Labs blood biomarker analysis.
- Company facts: founded in 2012, headquartered in Boston, raised more than $400 million in venture capital (before the Series G), ships to 56 countries, operates in six languages.
- Peer-reviewed research cited: daily wearers increase weekly exercise by more than 90 minutes, gain over two hours of sleep per week and improve heart rate variability by 10%.
- Whoop CEO: How the Pros Really Recover (The Rich Roll Podcast)
- Will Ahmed, founder and CEO, on WHOOP's positioning against Garmin and Apple: start with elite athletes, measure strain and recovery, no screen; "We weren't building a smartwatch."
- Product trade-off: smartwatches often have 24 hours or less of battery life, while "The latest Whoop has 14 days"; he says Apple "can't really measure sleep".
- The 2012 business plan set the arc: start with the world's best athletes, then consumers, then medicine; he says the company has followed it, with "a lot of zigs and zags" (business model, capital, nearly running out of money).
- Heart rate variability is "the metric that led me to found Whoop"; continuous data is why the device has no screen and a modular battery pack.
- Accuracy is built on hundreds of thousands of data sets from Whoop Labs comparing the wrist sensor with chest straps, across diverse athletes.
- AI: structured 24/7 data will sit under an LLM acting as a "247 coach or doctor"; "a big update coming" for the in-app coach.
- In two to three years he expects wearable data, blood tests and other data sets "under one roof" with an AI on top, changing the relationship with the doctor's office and preventive care.
- Organisation: the Boston office near Fenway Park is "filled with 500 employees"; he backed a return to the office during COVID against his board's view.
Questions about WHOOP
What does WHOOP do?
WHOOP sells a screenless wearable as a membership. It measures strain, recovery and sleep around the clock and adds health features such as an FDA-cleared ECG, Blood Pressure Insights and Advanced Labs blood testing, with AI coaching in its app.
How big is WHOOP?
WHOOP has over 2.5 million members and exited 2025 with a $1.1B bookings run rate after 103% year-over-year growth; it operated cash flow positive in 2025 and was valued at $10.1 billion in March 2026.
Who owns WHOOP?
WHOOP is a private, venture-backed company. Its Series G was led by Collaborative Fund, with investors such as the Qatar Investment Authority, Mubadala, Abbott and Mayo Clinic; the CEO says the next step is an IPO.
Who leads WHOOP?
Will Ahmed founded WHOOP in 2012 as a Harvard student-athlete, with John Capodilupo and Aurelian Nicolae, and is its CEO.
What is WHOOP's strategy?
It aims to become a personal health platform for preventive health, expanding internationally across Europe, the GCC, Latin America and Asia and adding more than 600 roles in 2026.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)